Document Detail


The Tumor Growth Paradox and Immune System-Mediated Selection for Cancer Stem Cells.
MedLine Citation:
PMID:  23196354     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cancer stem cells (CSCs) drive tumor progression, metastases, treatment resistance, and recurrence. Understanding CSC kinetics and interaction with their nonstem counterparts (called tumor cells, TCs) is still sparse, and theoretical models may help elucidate their role in cancer progression. Here, we develop a mathematical model of a heterogeneous population of CSCs and TCs to investigate the proposed "tumor growth paradox"-accelerated tumor growth with increased cell death as, for example, can result from the immune response or from cytotoxic treatments. We show that if TCs compete with CSCs for space and resources they can prevent CSC division and drive tumors into dormancy. Conversely, if this competition is reduced by death of TCs, the result is a liberation of CSCs and their renewed proliferation, which ultimately results in larger tumor growth. Here, we present an analytical proof for this tumor growth paradox. We show how numerical results from the model also further our understanding of how the fraction of cancer stem cells in a solid tumor evolves. Using the immune system as an example, we show that induction of cell death can lead to selection of cancer stem cells from a minor subpopulation to become the dominant and asymptotically the entire cell type in tumors.
Authors:
Thomas Hillen; Heiko Enderling; Philip Hahnfeldt
Related Documents :
2645044 - New vistas for leucovorin in cancer chemotherapy.
10442354 - Clinical implications of 5-fu modulation.
21098274 - Malignant cells facilitate lung metastasis by bringing their own soil.
23929794 - Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchym...
8144394 - Circumvention of atypical multidrug resistance with tumor necrosis factor.
1576684 - Inhibition of deoxyribonucleic acid synthesis in vitro by anticancer platinum pyrimidin...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-30
Journal Detail:
Title:  Bulletin of mathematical biology     Volume:  -     ISSN:  1522-9602     ISO Abbreviation:  Bull. Math. Biol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401404     Medline TA:  Bull Math Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Centre for Mathematical Biology, Mathematical and Statistical Sciences, University of Alberta, Edmonton, T6G 2G1, Canada, thillen@ualberta.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modelling the Dynamics of Crystal Meth ('Tik') Abuse in the Presence of Drug-Supply Chains in South ...
Next Document:  Creating a genotype-based dosing algorithm for acenocoumarol steady dose.